Smith & Nephew (SN.)

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (which includes arthroscopic procedures referred to as sports medicine) and advanced wound management. It operates in three segments: Orthopaedics, Endoscopy and Advanced Wound Management. It operates on a worldwide basis and has distribution channels in over 90 countries. Orthopaedic reconstruction implants include hip, knee and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. Endoscopy business develops and commercialises endoscopic (minimally invasive surgery) techniques, educational programmes and services. Advanced Wound Management business offers a range of products from initial wound bed preparation through to full wound closure. In May 2012, it acquired Kalypto Medical, Inc. In December 2012, the Company acquired the assets of Healthpoint Biotherapeutics.

Directors: Olivier Bohuon (CEO) 54, Julie Brown (CFO) 50, Michael Frazzette (Corp. Exec.) 50, Kelvin Johnson (Corp. Exec.) 61, Roger Teasdale (Corp. Exec.) 45, Francisco Vega (Corp. Exec.) 51, R. Gordon Howe (Sr. VP) 50, Ros Rivaz (CTO) 57, John Campo (Other) 58, Helen Maye (Other) 53,

No. of Employees: 10,500 No. of Shareholders: 19,122

Last Annual	December 31st, 2012
Last Interim	March 30th, 2013
Shares in Issue	903,452,899
Free Float	892.2m (98.8%)

Sector	Healthcare
Industry	Healthcare Equipment & Supplies
Index	FTSEUROFIRST 300 , E300 ex EURO COR, FTSE 350 Act , FTSE Lower Yield , FT350 Hlth Eq&sr , FTSE 100 , FTSE 100 Eod Gbp , FTSE Techmark Focus , FTSE Techmark All-share,
Exchange	London Stock Exchange (Full)
Eligible for	an ISA? a SIPP?